NCT07518745
TMS for iEEG Monitoring Recordings
Enrolling by Invitation
NAAges 21–75InterventionalBasic scienceUniversity of PennsylvaniaInvestigator-initiated
~10 participants
Updated 2026-05-01 on ClinicalTrials.gov
What's tested:Single Pulse TMS
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Endpoint #1 Brain Activity and Connectivity
Measured over From enrollment to the end of study participation at 5 weeks
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Primary Endpoint #1 Brain Activity and ConnectivityFrom enrollment to the end of study participation at 5 weeks
Observation of effects in brain activity and connectivity within and across regions of interest before and after TMS, as measured by intracranial EEG. The evoked response magnitude from the EEG at all features of the time-frequency analysis are used.
- Primary Endpoint #2: Safety FeasibilityFrom enrollment to end of study participation at 5 weeks.
Safety, as defined by the number of adverse events (AE)